-
Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer
Oct 29, 2019, 12:25 PM by Michael CroftHAIFA, ISRAEL - Oct 29, 2019 - MeMed Ltd., a leader in host response-based diagnostic solutions, today announced the addition of DrFull story -
Alfa Chemistry Launched Microalgae Powder Services
Oct 29, 2019, 04:58 AM by Michael CroftNEW YORK, NY, UNITED STATES - Oct 29, 2019 - On October 24, 2019, Alfa Chemistry announced that it has launched microalgae powder production servicesFull story -
Sterling Pharma Solutions invests $1.5m into US facility expansion
Oct 28, 2019, 11:43 AM by Michael CroftNORTH CAROLINA, N/A - Oct 28, 2019 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1Full story -
ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies
Oct 28, 2019, 10:29 AM by Michael CroftSCHILTHIGHEIM, FRANCE - Oct 28, 2019 - For researchers looking to accelerate the development of new immunotechnologies, ProteoGenix has created 2 new naïve rabbit and human antibody phage display librariesFull story -
Half Of Lab Experiments Fail, Costing $28B Annually. How We Can Prevent ‘Unknown Unknowns’
Oct 28, 2019, 08:50 AM by Michael CroftFull storyBio-IT World Contributed Commentary | PLOS Biology published data on the $28 billion lost in preclinical research back in June 2015. It raised a vital question: What is the life science community actually doing now to prevent this colossal amount of wasted time, money, effort, and inventory?
-
A prediction of gene sequencing application areas and scale by CD Genomics
Oct 28, 2019, 03:47 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Oct 28, 2019 - The upstream of the gene sequencing industry is the supply of sequencing instruments, sequencing reagents and consumablesFull story -
BOC Sciences Upgrades Bioconjugation Service to Help Advance Targeted Drug Delivery Research
Oct 27, 2019, 21:58 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Oct 22, 2019 - Targeted drug delivery is by no means easy task, but luckily bioconjugation can be of great assistanceFull story -
Creative Proteomics Provides Glycosylation Service for Lab Research
Oct 25, 2019, 02:34 AM by Michael CroftSHIRLEY, NY - Oct 25, 2019 - Since its establishment in 2004, Creative Proteomics has gradually been a leading supplier providing proteomics, glycomics, metabolomics and bioinformatics analysis servicesFull story -
Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
Oct 24, 2019, 14:11 PM by Michael CroftHOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infectionFull story -
The Greatest Medical Advancements Of The Future Will Originate In Data-Driven Enterprises
Oct 24, 2019, 11:30 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Combining the core competencies of life sciences and medicine with data-driven solutions will enable researchers and providers to revolutionize healthcare.
-
KCR Announces new Chief Technology Officer
Oct 24, 2019, 09:15 AM by Michael CroftBOSTON, MA, US - Oct 24, 2019 - KCR, an international clinical development solutions provider, has named Douglas Bain the organizations Chief Technology OfficerFull story -
TrialScope Acquires Clinical Trial Connect
Oct 24, 2019, 09:11 AM by Michael CroftJERSEY CITY, NJ, US - Oct 24, 2019 - TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trialsFull story -
MR Solutions’ new preclinical imaging PET/CT range on display at EANM ‘19
Oct 24, 2019, 05:07 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Oct 24, 2019 - MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM 19, (European Association of Nuclear Medicine) last week in BarcelonaFull story -
ZEISS expands its portfolio of microscope cameras
Oct 23, 2019, 10:15 AM by Michael CroftCHICAGO, IL, UNITED STATES - Oct 23, 2019 - ZEISS introduces four new high-quality CMOS cameras for digital imaging in light microscopy. These cameras complete the portfolio of proven ZEISS Axiocam models which stand for excellent performance in demanding microscopy applicationsFull story -
New Standards, Initiatives For GA4GH
Oct 23, 2019, 06:00 AM by Michael CroftFull storyBio-IT World | The Global Alliance for Genomics and Health (GA4GH) yesterday announced the unanimous approval of five new standards to enable responsible international genomic data sharing.
-
Accumen Acquires Medical Imaging Post-Processing Company 3DR Laboratories
Oct 22, 2019, 14:42 PM by Michael CroftPHOENIX, AZ - Oct 22, 2019 - Accumen Inc., the leader in healthcare performance, today announced that it has acquired 3DR Laboratories, the largest and most respected 3D medical post-processing laboratory in the United StatesFull story -
Leading Pediatric Cancer Center Selects Petagene’s Genomic Data Compression Solutions for Informatics Infrastructure
Oct 22, 2019, 07:28 AM by Michael CroftCAMBRIDGE, UK - Oct 22, 2019 - PetaGene today announced that Princess Máxima Center for Pediatric Oncology, the largest pediatric cancer center in Europe, has chosen to use PetaGenes transparent, lossless genomic data compression software, called PetaSuite, to reduce its data storage costs while accelerating access to the dataFull story -
As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
Oct 22, 2019, 06:28 AM by Michael CroftKING OF PRUSSIA, PA - Oct 22, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractorsFull story -
A New Marketplace For Machine Learning Researchers—And Citizen Scientists
Oct 22, 2019, 06:00 AM by Michael CroftFull storyBio-IT World | A nonprofit devoted to citizen science has been working with biomedical researchers at Cornell University to apply crowd power and artificial intelligence (AI) to questions neither humans nor machines could answer alone.
-
Enhancing ZEISS Celldiscoverer 7 with ZEISS LSM 900 for optical sectioning
Oct 21, 2019, 12:06 PM by Michael Croft- Oct 21, 2019 - The proven ZEISS Celldiscoverer 7 is a fully integrated high-end imaging system with various incubation and detection optionsFull story